← All investors

MV

Firm & fund profile / Sourced portfolio

Menlo Ventures

Tracked participation in 17 Atlas companies, with 9 explicitly attributed leads.

Firm website ↗

17portfolio companies

25round participations

9lead positions

$927.9Mled round total

Conviction

Most recent leads

The latest rounds this investor is sourced as leading, newest first.

Aug 2026LovableSeries C$400Mat $13.3B valuation Nov 2025SunoSeries C$250Mat $2.5B valuation Nov 2025InceptionSeed$50M Aug 2025Chai DiscoverySeries A$70M Jun 2025OpenRouterSeed and Series A (combined)$40MApr 2025GoodfireSeries A$50M

Capital activity

Portfolio

CompanyLatest valuationFirst → latestRoundsRoleAttributed partner

LLovable$13.3BAug 2026 → Aug 20261 round1 led—

FAFireworks AI$17.5BJul 2026 → Jul 20261 roundParticipant—

SSuno$5.4BNov 2025 → Jun 20262 rounds1 led—

OOpenRouter$1.3BJun 2025 → May 20262 rounds1 led—

MModal$4.7BMay 2026 → May 20261 roundParticipant—

LLegora$5.6BMar 2026 → Mar 20261 roundParticipant—

AAnthropic$380BMar 2025 → Feb 20262 roundsParticipant—

GGoodfire$1.3BApr 2025 → Feb 20262 rounds1 led—

IInception—Nov 2025 → Nov 20251 round1 led—

CDChai Discovery—Aug 2025 → Aug 20251 round1 led—

PIPrime IntellectNeo-labsPrime Intellect builds a full-stack, “open superintelligence” platform for teams that want to train, evaluate, and…$1Bvaluation$150.5MraisedRecent roundsSeries A · Jul 2026$130M · led by Radical VenturesSeed (announced as $15M to build the open superintelligence stack) · Feb 2025$15M · led by Founders FundSeed · Apr 2024$5.5M · Clem Delangue, Clem Delangue (Hugging Face) +7Prime Intellect—Feb 2025 → Feb 20251 roundParticipant—

MMercor$2BFeb 2025 → Feb 20251 roundParticipant—

SASkild AI$1.5BJul 2024 → Jul 20241 roundParticipant—

LLindy—Jan 2021 → Sep 20233 rounds1 ledNaomi Ionita

SSana$180MDec 2022 → Dec 20221 round1 led—

CClarifai—Oct 2016 → Oct 20212 rounds1 led—

RRecursionScienceRecursion (NASDAQ: RXRX) is a clinical-stage TechBio company developing an end-to-end, AI-native drug discovery and…$1.2BraisedRecent roundsPublic Offering (equity) · Jun 2024$200M · Public market investors (follow-on offering)PIPE / strategic investment (NVIDIA investment) · Jul 2023$50M · NVIDIADebt financing (credit facility / term loan) · Jan 2023$11.9M · led by Midcap Financial Trust (Midcap)Recursion—Oct 2017 → Jul 20192 roundsParticipant—

DateCompanyRoundRaisedValuationRoleEvidence

Aug 12, 2026LLovableSeries C$400M$13.3BLead

Jul 15, 2026FAFireworks AISeries D$1.5B$17.5BParticipant

Jun 03, 2026SSunoSeries D$400M$5.4BParticipant

May 28, 2026OOpenRouterSeries B$113M$1.3BParticipant

May 21, 2026MModalSeries C$355M$4.7BParticipant

Mar 10, 2026LLegoraSeries D$550M$5.6BParticipant

Feb 12, 2026AAnthropicSeries G$30B$380BParticipant

Feb 05, 2026GGoodfireSeries B$150M$1.3BParticipant

Nov 19, 2025SSunoSeries C$250M$2.5BLead

Nov 06, 2025IInceptionSeed$50M—Lead

Aug 06, 2025CDChai DiscoverySeries A$70M—Lead

Jun 25, 2025OOpenRouterSeed and Series A (combined)$40M—Lead

Source ↗+1 ↗

Apr 17, 2025GGoodfireSeries A$50M—Lead

Mar 03, 2025AAnthropicSeries E$3.5B$61.5BParticipant

Feb 28, 2025PIPrime IntellectNeo-labsPrime Intellect builds a full-stack, “open superintelligence” platform for teams that want to train, evaluate, and…$1Bvaluation$150.5MraisedRecent roundsSeries A · Jul 2026$130M · led by Radical VenturesSeed (announced as $15M to build the open superintelligence stack) · Feb 2025$15M · led by Founders FundSeed · Apr 2024$5.5M · Clem Delangue, Clem Delangue (Hugging Face) +7Prime IntellectSeed (announced as $15M to build the open superintelligence stack)$15M—Participant

Feb 20, 2025MMercorSeries B$100M$2BParticipant

Jul 09, 2024SASkild AISeries A$300M$1.5BParticipant

Sep 12, 2023LLindyRepositioning into Lindy using existing cap table (not a new funding round)——Participant

Dec 13, 2022SSanaSeries B$34M$180MLead

Oct 15, 2021CClarifaiSeries C$60M—Participant

Jul 26, 2021LLindySeries B (Teamflow)$35M—Participant · Naomi Ionita

Jan 06, 2021LLindySeed (Teamflow)$3.9M—Lead · Naomi Ionita

Source ↗+1 ↗

Jul 15, 2019RRecursionScienceRecursion (NASDAQ: RXRX) is a clinical-stage TechBio company developing an end-to-end, AI-native drug discovery and…$1.2BraisedRecent roundsPublic Offering (equity) · Jun 2024$200M · Public market investors (follow-on offering)PIPE / strategic investment (NVIDIA investment) · Jul 2023$50M · NVIDIADebt financing (credit facility / term loan) · Jan 2023$11.9M · led by Midcap Financial Trust (Midcap)RecursionSeries C$121M—Participant

Oct 03, 2017RRecursionScienceRecursion (NASDAQ: RXRX) is a clinical-stage TechBio company developing an end-to-end, AI-native drug discovery and…$1.2BraisedRecent roundsPublic Offering (equity) · Jun 2024$200M · Public market investors (follow-on offering)PIPE / strategic investment (NVIDIA investment) · Jul 2023$50M · NVIDIADebt financing (credit facility / term loan) · Jan 2023$11.9M · led by Midcap Financial Trust (Midcap)RecursionSeries B$60M—Participant

Oct 25, 2016CClarifaiSeries B$30M—Lead

DateCompanyRoundRaisedValuationRoleEvidence

Feb 12, 2026AAnthropicSeries G$30B$380BParticipant

Mar 03, 2025AAnthropicSeries E$3.5B$61.5BParticipant

Jul 15, 2026FAFireworks AISeries D$1.5B$17.5BParticipant

Mar 10, 2026LLegoraSeries D$550M$5.6BParticipant

Aug 12, 2026LLovableSeries C$400M$13.3BLead

Jun 03, 2026SSunoSeries D$400M$5.4BParticipant

May 21, 2026MModalSeries C$355M$4.7BParticipant

Jul 09, 2024SASkild AISeries A$300M$1.5BParticipant

Nov 19, 2025SSunoSeries C$250M$2.5BLead

Feb 05, 2026GGoodfireSeries B$150M$1.3BParticipant

Jul 15, 2019RRecursionScienceRecursion (NASDAQ: RXRX) is a clinical-stage TechBio company developing an end-to-end, AI-native drug discovery and…$1.2BraisedRecent roundsPublic Offering (equity) · Jun 2024$200M · Public market investors (follow-on offering)PIPE / strategic investment (NVIDIA investment) · Jul 2023$50M · NVIDIADebt financing (credit facility / term loan) · Jan 2023$11.9M · led by Midcap Financial Trust (Midcap)RecursionSeries C$121M—Participant

May 28, 2026OOpenRouterSeries B$113M$1.3BParticipant

Feb 20, 2025MMercorSeries B$100M$2BParticipant

Aug 06, 2025CDChai DiscoverySeries A$70M—Lead

Oct 15, 2021CClarifaiSeries C$60M—Participant

Oct 03, 2017RRecursionScienceRecursion (NASDAQ: RXRX) is a clinical-stage TechBio company developing an end-to-end, AI-native drug discovery and…$1.2BraisedRecent roundsPublic Offering (equity) · Jun 2024$200M · Public market investors (follow-on offering)PIPE / strategic investment (NVIDIA investment) · Jul 2023$50M · NVIDIADebt financing (credit facility / term loan) · Jan 2023$11.9M · led by Midcap Financial Trust (Midcap)RecursionSeries B$60M—Participant

Nov 06, 2025IInceptionSeed$50M—Lead

Apr 17, 2025GGoodfireSeries A$50M—Lead

Jun 25, 2025OOpenRouterSeed and Series A (combined)$40M—Lead

Source ↗+1 ↗

Jul 26, 2021LLindySeries B (Teamflow)$35M—Participant · Naomi Ionita

Dec 13, 2022SSanaSeries B$34M$180MLead

Oct 25, 2016CClarifaiSeries B$30M—Lead

Feb 28, 2025PIPrime IntellectNeo-labsPrime Intellect builds a full-stack, “open superintelligence” platform for teams that want to train, evaluate, and…$1Bvaluation$150.5MraisedRecent roundsSeries A · Jul 2026$130M · led by Radical VenturesSeed (announced as $15M to build the open superintelligence stack) · Feb 2025$15M · led by Founders FundSeed · Apr 2024$5.5M · Clem Delangue, Clem Delangue (Hugging Face) +7Prime IntellectSeed (announced as $15M to build the open superintelligence stack)$15M—Participant

Jan 06, 2021LLindySeed (Teamflow)$3.9M—Lead · Naomi Ionita

Source ↗+1 ↗

Sep 12, 2023LLindyRepositioning into Lindy using existing cap table (not a new funding round)——Participant